25 May 2023
Rural and regional health and workforce discussed this week
Updates from AMA Council of Rural Doctors and a report on regional skills in the National Press Club this week
25 May 2023
Agreement failing our public hospitals
The AMA has found the key objectives of the agreement governing Australia’s public hospitals are not being met and needs a comprehensive makeover.
25 May 2023
Restrict title of ‘surgeon’ to protect patients, AMA tells hearing
The AMA told a parliamentary committee examining new laws to regulate cosmetic surgery, that strict rules on who can be called a ‘surgeon’ are needed in the National Law to protect patients.
25 May 2023
Bowel cancer screening alternative access to kits model
Patients will be able to receive screening kits directly from healthcare providers.
25 May 2023
More detail on the federal budget for GPs
The AMA is sifting through the details of the budget and will keep members updated.
25 May 2023
AMA emphasises need for COVID and flu shots as colder winter weather rolls in
AMA Vice President Dr Danielle McMullen this week highlighted the importance of people getting flu and COVID shots to protect themselves this winter warned of the physical health and mental health dangers of using illegal “nangs” or nitrous oxide.
25 May 2023
Coping with feelings of failure
Drs4Drs offer free and confidential services around the clock for doctors and students, and this week offer some thoughts on coping with feelings of failure.
24 May 2023
‘Misused evidence’: Spotlight on alcohol industry submissions
New research looking at alcohol industry contributions to inform national strategy has found numerous ways science is misrepresented.
24 May 2023
RACGP raises questions over impending PSR changes
A representative says the college supports greater transparency and fairness around compliance, but notes the approach must be balanced.
24 May 2023
PBAC Public Summary Documents
The Public Summary Document of the Pharmaceutical Benefits Advisory Committee’s (PBAC) consideration of the interim report of the Post-market Review of Opioid Dependence Treatment Program medicines which was considered out-of-session between March 2023 and July 2023 by the PBAC is now available.